IDEXX CEO succession: Mike Erickson to become President and CEO on May 12, 2026; Mazelsky to Executive Chair

IDEXX LABORATORIES INC /DE

Jay Mazelsky steps down as CEO effective May 12, 2026, transitions to Executive Chair; will retire from board in May 2027.
Michael Erickson, PhD (EVP & GM Global Point of Care), promoted to President and CEO, joining the board.
Erickson's compensation: $1M base salary, 120% target bonus, FY2026 equity target at least $7.8M (50% options, 50% PSUs).
Mazelsky's Executive Chair compensation: $1.15M base, blended bonus target, $8.275M RSU grant in Feb 2026.
Lawrence Kingsley, currently Non-Executive Chair, becomes independent Lead Director after transition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.